Ancient Pharmacuetical Industries Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 04-07-2024
- Paid Up Capital ₹ 5.50 M
as on 04-07-2024
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 99.73%
(FY 2022)
- Ebitda 99.73%
(FY 2022)
- Net Worth -22.73%
(FY 2022)
- Total Assets %
(FY 2022)
About Ancient Pharmacuetical Industries
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 5.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jagdish Goyal, Abhishek Goyal, and Mohit Goyal serve as directors at the Company.
- CIN/LLPIN
U52371DL1989PLC035179
- Company No.
035179
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Feb 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ancient Pharmacuetical Industries?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Goyal  | Director | 07-Oct-2020 | Current |
| Jagdish Goyal | Director | 07-Oct-2020 | Current |
| Mohit Goyal | Director | 07-Oct-2020 | Current |
Financial Performance of Ancient Pharmacuetical Industries.
Ancient Pharmacuetical Industries Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.73% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ancient Pharmacuetical Industries?
In 2022, Ancient Pharmacuetical Industries had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Motif Electric LimitedActive 30 years 11 monthsJagdish Goyal, Abhishek Goyal and 1 more are mutual person
- Polymet Films Private LimitedActive 3 years 1 month
Jagdish Goyal, Abhishek Goyal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ancient Pharmacuetical Industries?
Unlock and access historical data on people associated with Ancient Pharmacuetical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ancient Pharmacuetical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ancient Pharmacuetical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
